Fluconazole Dosing for Candiduria in Dialysis Patients
For candiduria in dialysis patients, oral fluconazole 200 mg daily for 2 weeks is recommended for fluconazole-susceptible Candida species, with dosing after each hemodialysis session in patients on intermittent hemodialysis. 1, 2
Candiduria Management Algorithm
Step 1: Determine Need for Treatment
- Asymptomatic candiduria generally does not require treatment unless the patient belongs to a high-risk group (neutropenic patients, very low birth weight infants, or patients undergoing urologic manipulation) 1
- Dialysis patients with candiduria should be evaluated for symptoms and risk of dissemination before initiating treatment 1
- Removal of indwelling bladder catheters, if present, is strongly recommended as this alone may resolve candiduria in nearly half of cases 1, 3
Step 2: Identify Candida Species and Susceptibility
- Determine the Candida species and fluconazole susceptibility before initiating therapy 1
- C. albicans accounts for approximately 60% of urinary Candida isolates and is typically fluconazole-susceptible 3
- C. glabrata and C. krusei often have reduced susceptibility to fluconazole and may require alternative therapy 1
Step 3: Fluconazole Dosing in Dialysis Patients
For fluconazole-susceptible organisms:
For fluconazole-resistant C. glabrata:
- Amphotericin B deoxycholate 0.3-0.6 mg/kg daily for 1-7 days OR
- Oral flucytosine 25 mg/kg 4 times daily for 7-10 days 1
For C. krusei infections:
- Amphotericin B deoxycholate 0.3-0.6 mg/kg daily for 1-7 days 1
Special Considerations for Dialysis Patients
- Fluconazole is primarily eliminated by renal excretion as unchanged drug, requiring dose adjustment in renal impairment 2, 4
- Hemodialysis removes a significant amount of fluconazole, necessitating supplemental dosing after each dialysis session 2, 4
- The half-life of fluconazole is significantly prolonged in patients with severe renal impairment (101.9 hours in patients with creatinine clearance 11-20 mL/min vs. 36.7 hours in patients with normal renal function) 4
Management of Complicated Candiduria in Dialysis Patients
For pyelonephritis without dissemination:
For patients with fungal balls or obstructive uropathy:
Common Pitfalls and Caveats
- Failure to confirm candiduria with a second urine culture may lead to unnecessary treatment of contamination 3
- Inadequate dosing in dialysis patients can result in treatment failure; ensure proper post-dialysis supplementation 2, 4
- Continuing indwelling catheters during treatment significantly reduces cure rates; remove catheters whenever possible 1
- Fluconazole resistance may develop during therapy, particularly with C. glabrata; monitor clinical response and consider follow-up cultures if improvement is not observed 1
- Concomitant medications may affect renal function; monitor closely, especially when using nephrotoxic agents 6